- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/14 - 1,4-BenzodiazepinesHydrogenated 1,4-benzodiazepines
Patent holdings for IPC class C07D 243/14
Total number of patents in this class: 146
10-year publication summary
|
5
|
3
|
32
|
12
|
8
|
8
|
4
|
4
|
7
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| VALO Health, Inc. | 193 |
34 |
| Hoffmann-La Roche Inc. | 3804 |
4 |
| Cytokinetics, Inc. | 251 |
4 |
| Forma Therapeutics, Inc. | 147 |
4 |
| PAION UK Limited | 44 |
4 |
| Bristol-myers Squibb Company | 4747 |
3 |
| Constellation Pharmaceuticals, Inc. | 219 |
3 |
| Gilead Sciences, Inc. | 2226 |
3 |
| Sanford Burnham Prebys Medical Discovery Institute | 309 |
3 |
| Merck Sharp & Dohme LLC | 3737 |
3 |
| Ningbo Combireg Pharmaceutical Technology Co., Ltd. | 10 |
3 |
| F. Hoffmann-La Roche AG | 7816 |
2 |
| Genentech, Inc. | 4113 |
2 |
| The Regents of the University of Michigan | 5002 |
2 |
| Abbvie Inc. | 1823 |
2 |
| Actelion Pharmaceuticals Ltd | 492 |
2 |
| Araxes Pharma LLC | 90 |
2 |
| Baruch S. Blumberg Institute | 35 |
2 |
| BP Oil International Limited | 71 |
2 |
| Eagle Pharmaceuticals, Inc. | 102 |
2 |
| Other owners | 60 |